AZ mulls buy-or-sell options for Indian unit

AstraZeneca ($AZN) may buy out minority shareholders in its Indian unit, snapping up the 10% share it doesn't already own and delisting the company. Or it may sell off some of its interest, in advance of new rules that limit foreign stakes in Indian companies to 75%. Report